Meaghan Mooney, B.S.N., RN, OCN, Receives CURE’s 2024 Extraordinary Healer® Award
Over 500 attendees at this in-person event celebrated the incredible efforts made by oncology nurses when caring for patients with cancer.
Over 500 attendees at this in-person event celebrated the incredible efforts made by oncology nurses when caring for patients with cancer.
The combination of lenvatinib and pembrolizumab has demonstrated activity as fourth-line therapy in patients with advanced ovarian cancer.
For breast cancer that is estrogen receptor–positive, CDK4/6 inhibitors, given with endocrine therapy, have become the standard of care, especially in metastatic disease. However, resistance…
AbstractBackground. Electronic health record–linked portals may improve health-care quality for patients with cancer. Barriers to portal access and use undermin
Dr. Meagan Krupa came to MD Anderson from Alaska after watching its specialists expertly guide a relative’s local cancer care. Here, she received a corrected…
TSP is a reliable marker of clinical outcome measures, including platinum chemoresistance, PFS, and OS, in high-grade serous ovarian cancer.
2233 S Martin Luther King Dr Chicago, IL 60616 Join Healio | HemOnc Today as we celebrate the risk-takers and groundbreakers at this prestigious awards…
This randomized clinical trial evaluates whether a multilevel advance care planning (ACP) intervention improves clinician ACP documentation for patients with advanced genitourinary cancers compared with…
The field of oncology is experiencing a revolution driven by artificial intelligence (AI) technology. Artificial intelligence tools are already being used in medical imaging analysis,…
HPV vaccines in patients under the age of 40 may have lowered rates of HPV-related cancer compared with unvaccinated patients.
The standard treatment paradigm for muscle invasive bladder cancer has been neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy. However, efforts are ongoing to personalize treatment…